A novel cancer vaccine strategy based on HLA-A*0201 matched allogeneic plasmacytoid dendritic cells. by Caroline Aspord, Julie Charles, Marie-Therese Leccia, David Laurin, Marie-Jeanne Richard, Laurence Chaperot, Joel Plumas

Get full text

Engineering a Human Plasmacytoid Dendritic Cell-Based Vaccine to Prime and Expand Multispecific Viral and Tumor Antigen-Specific T-Cells by Kevin Lenogue, Alexandre Walencik, Karine Laulagnier, Jean-Paul Molens, Houssem Benlalam, Brigitte Dreno, Pierre Coulie, Martin Pule, Laurence Chaperot, Joël Plumas

Get full text

Death receptor 6 is a novel plasmacytoid dendritic cell-specific receptor and modulates type I interferon production by Jingyun Li, Qiumei Du, Rui Hu, Yanbing Wang, Xiangyun Yin, Haisheng Yu, Peishuang Du, Joël Plumas, Laurence Chaperot, Yong-jun Liu, Liguo Zhang

Get full text

Endothelial cell-derived microparticles induce plasmacytoid dendritic cell maturation: potential implications in inflammatory diseases by Fanny Angelot, Estelle Seillès, Sabeha Biichlé, Yael Berda, Béatrice Gaugler, Joel Plumas, Laurence Chaperot, Françoise Dignat-George, Pierre Tiberghien, Philippe Saas, Francine Garnache-Ottou

Get full text

The features of circulating and tumor-infiltrating γδ T cells in melanoma patients display critical perturbations with prognostic impact on clinical outcome by Pauline Girard, Julie Charles, Camille Cluzel, Emmanuelle Degeorges, Olivier Manches, Joel Plumas, Florence De Fraipont, Marie-Therese Leccia, Stephane Mouret, Laurence Chaperot, Caroline Aspord

Get full text

Pegylated Interferon α-2a Triggers NK-Cell Functionality and Specific T-Cell Responses in Patients with Chronic HBV Infection without HBsAg Seroconversion. by Juliana Bruder Costa, Tania Dufeu-Duchesne, Vincent Leroy, Inga Bertucci, Magali Bouvier-Alias, Noelle Pouget, Ophelie Brevot-Lutton, Marc Bourliere, Fabien Zoulim, Joel Plumas, Caroline Aspord, ANRS HB06 PEGAN study group

Get full text